Tìm kiếm thay thế:
harm » arm (Mở rộng tìm kiếm), farm (Mở rộng tìm kiếm), hard (Mở rộng tìm kiếm)
Đang hiển thị 41 - 60 kết quả của 1,877 cho tìm kiếm 'harm is (((((resolved. OR involves.) OR involves.) OR resolvedddsds.) OR involved.) OR resolve.)*', thời gian truy vấn: 0.56s Tinh chỉnh kết quả
  1. 41
    Gender differences among various self-harm variables.

    Gender differences among various self-harm variables. Bằng Willie Njoroge (20623714)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:
  2. 42
    Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings.

    Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  3. 43
    Results of comparing visits within allergy groups using linear mixed models and post hoc analysis.

    Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  4. 44
    Results of comparing allergy groups within visits using linear mixed models and post hoc analysis.

    Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  5. 45
    Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference.

    Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  6. 46
    Results of comparing treatment groups within visits using linear mixed models and post hoc analysis.

    Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  7. 47
    Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis.

    Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  8. 48
    Results of comparing visits within treatment groups using linear mixed models and post hoc analysis.

    Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  9. 49
    Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis.

    Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  10. 50
    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determined with ConsensusPathDB.

    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determ... Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  11. 51
    Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB.

    Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  12. 52
    Results of comparing allergy groups within visits using KEGG pathway enrichment in ConsensusPathDB.

    Results of comparing allergy groups within visits using KEGG pathway enrichment in ConsensusPathDB. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  13. 53
    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within treatment groups as determined with ConsensusPathDB.

    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within treatment groups as determ... Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  14. 54
    Results of comparing visits within treatment groups using KEGG pathway enrichment in ConsensusPathDB.

    Results of comparing visits within treatment groups using KEGG pathway enrichment in ConsensusPathDB. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  15. 55
    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within allergy groups as determined with ConsensusPathDB.

    KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between visits within allergy groups as determin... Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  16. 56
    Results of comparing visits within allergy groups using KEGG pathway enrichment in ConsensusPathDB.

    Results of comparing visits within allergy groups using KEGG pathway enrichment in ConsensusPathDB. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  17. 57
    Potential mechanisms for persistent CMA (left) and resolution of CMA (right) revealed by our study.

    Potential mechanisms for persistent CMA (left) and resolution of CMA (right) revealed by our study. Bằng Diana M. Hendrickx (1507435)

    Được phát hành 2025
    Lưu vào danh sách
    Đã lưu trong:
  18. 58
    Trends in the valuation of injury involving the face: an analysis on trial in Rio Grande do Sul, Brazil

    Trends in the valuation of injury involving the face: an analysis on trial in Rio Grande do Sul, Brazil Bằng Gabriela Cauduro da ROSA (4647883)

    Được phát hành 2020
    “…To measure the damage, the assessment of the bodily harm is required. Objective To analyze jurisprudential characteristics involving the valuation of the damage related to facial trauma, highlighting trends Methods It was analyzed secondary data, which are public domain, of the precedents of the Court of Justice of Rio Grande do Sul State from 2008 to 2016. …”
    Lưu vào danh sách
    Đã lưu trong:
  19. 59
    PRLR1 is involved in mediating dsRNA-response in <i>adar1(RNAi)</i> and <i>adar2(RNAi)</i> animals.

    PRLR1 is involved in mediating dsRNA-response in <i>adar1(RNAi)</i> and <i>adar2(RNAi)</i> animals. Bằng Dan Bar Yaacov (11965433)

    Được phát hành 2022
    Lưu vào danh sách
    Đã lưu trong:
  20. 60
    Votes in favor of lifting COVID-19 measures (Experiment 2).

    Votes in favor of lifting COVID-19 measures (Experiment 2). Bằng Besarta Veseli (12289504)

    Được phát hành 2025
    Những chủ đề:
    Lưu vào danh sách
    Đã lưu trong:

Công cụ tìm kiếm: